세계의 세포 분리 기술 시장 보고서(2025년)
Cell Separation Technologies Global Market Report 2025
상품코드 : 1825658
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세포 분리 기술 시장 규모는 향후 몇 년 동안 급성장할 것으로 예측됩니다. 2029년에는 CAGR 15.7%로 210억 3,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 재생의료 연구에 대한 투자 증가, 암 진단 및 치료 적용 확대, 세포 기반 치료 수요를 촉진하는 만성질환 유병률 증가, 새로운 세포 분리 기술의 출현, 세포치료제 개발 및 상용화에 대한 규제 당국의 지원 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 인공지능과 머신러닝의 통합, 마이크로플루이딕스 기반 플랫폼의 부상, 포인트 오브 케어 세포 분리 장치의 개발, 라벨 프리 분리 기술에 대한 관심 증가, 단일 세포 분리 기술의 채택, 재생의료 및 줄기세포 연구에서의 응용 확대, 새로운 세포 선별 방법의 등장 등이 있습니다.

향후 5년간 15.7%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과로 인해 대만과 핀란드에서 수입되는 마이크로플루이딕스 세포 분류기 및 라벨이 없는 분리 칩의 비용이 상승하고, 단일 세포 분석 워크플로우에 샘플당 50-100달러가 추가될 수 있어 미국의 정밀의료에 혼란을 초래할 수 있습니다. 또한, 상호 관세와 무역 마찰 및 무역 제한의 강화로 인한 세계 경제와 무역에 대한 악영향으로 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

만성 질환의 확산은 세포 분리 기술 시장의 확대를 촉진할 것으로 예측됩니다. 만성질환은 1년 이상 지속되고 지속적인 치료가 필요하거나 일상생활에 제한이 있는 질환으로 암, 심장병, 뇌졸중, 당뇨병, 관절염 등이 포함됩니다. 이러한 증가는 생활습관 선택, 사회적 격차, 감염, 유전, 자가면역, 정신 건강 문제 등 다양한 요인에 기인합니다. 세포분리 기술은 암세포, 면역세포, 기타 적절한 세포 유형을 분리할 수 있게 함으로써 만성질환의 치료를 앞당기는 데 중요한 역할을 하고 있습니다. 예를 들어, 미국 국립생물공학정보센터(NCBI)의 2023년 1월 예측에 따르면, 2050년까지 50세 이상 만성질환을 앓고 있는 사람의 수는 2020년 7,152만 2,000명에서 2050년까지 99.5% 증가하여 1억 4,266만 명에 달할 것으로 예상했습니다. 따라서 만성 질환의 급증은 세포 분리 기술 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Cell separation technologies encompass methodologies and implements employed to segregate particular cell types from a heterogeneous mix of cells. These technologies play a pivotal role in biomedical investigations, clinical diagnostics, and therapeutic endeavors, aiming to procure a purified population of target cells for subsequent analysis or utilization.

The primary products of cell separation technologies comprise instruments, consumables, and reagents. Instruments denote the apparatus utilized in cell separation procedures to streamline the isolation of specific cell subsets from biological samples. Diverse techniques encompass gradient centrifugation, surface marker separation, fluorescence-activated cell sorting, magnetic cell sorting, and filtration-based separation. An array of applications for cell separation technologies, spanning stem cell research, immunology, neuroscience, cancer research, and others, cater to a spectrum of end-users, including biotechnology and pharmaceutical firms, hospitals and diagnostic laboratories, academic and research establishments, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell separation technologies market research report is one of a series of new reports from The Business Research Company that provides cell separation technologies market statistics, including cell separation technologies industry global market size, regional shares, competitors with a cell separation technologies market share, detailed cell separation technologies market segments, market trends and opportunities, and any further data you may need to thrive in the cell separation technologies industry. This cell separation technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell separation technologies market size has grown rapidly in recent years. It will grow from $10.07 billion in 2024 to $11.73 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. The growth in the historic period can be attributed to increasing demand for personalized medicine, high cases of chronic diseases, increasing funding for life sciences research, expanded biotechnology industry, technological innovations, and high applications in regenerative medicine.

The cell separation technologies market size is expected to see rapid growth in the next few years. It will grow to $21.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to rising investments in regenerative medicine research, expanding applications in cancer diagnostics and treatment, growing prevalence of chronic diseases driving demand for cell-based therapies, the emergence of novel cell separation techniques, and regulatory support for cell therapy development and commercialization. Major trends in the forecast period include the integration of artificial intelligence and machine learning, the rise of microfluidic-based platforms, the development of point-of-care cell separation devices, increasing focus on label-free separation techniques, adoption of single-cell isolation technologies, expansion of applications in regenerative medicine and stem cell research, and the emergence of novel cell sorting methods.

The forecast of 15.7% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. precision medicine by increasing costs for microfluidic cell sorters and label-free separation chips imported from Taiwan and Finland, potentially adding $50-100 per sample to single-cell analysis workflows. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The escalating prevalence of chronic diseases is expected to drive the expansion of the cell separation technology market. Chronic diseases, lasting a year or longer and necessitating ongoing medical attention or limiting daily activities, include cancer, heart disease, stroke, diabetes, and arthritis. This rise can be attributed to various factors such as lifestyle choices, social disparities, infections, genetics, autoimmunity, and mental health concerns. Cell-separation technologies play a crucial role in advancing treatments for chronic diseases by enabling the isolation of cancer cells, immune cells, and other pertinent cell types. For example, according to the National Center for Biotechnology Information (NCBI), it was projected in January 2023 that by 2050, the number of individuals aged 50 and above with at least one chronic illness will increase by 99.5%, reaching 142.66 million from 71.522 million in 2020. Hence, the surge in chronic disease prevalence is fueling the growth of the cell separation technology market.

Major players in the cell separation technologies market prioritize the development of advanced solutions such as automated cell isolation technology. This technology aims to enhance precision, improve efficiency, and streamline workflows in cell sorting and therapy development. Automated cell isolation involves the utilization of automated equipment to separate specific cells from mixed cell populations. For example, in October 2022, Thermo Fisher Scientific introduced the Gibco CTS DynaCellect Magnetic Separation System. This closed system is automated and facilitates precise cell isolation, activation, depletion, and removal of Dynabeads magnetic beads. Its purpose is to aid cell therapy developers in seamlessly transitioning from clinical development to commercial production, providing scalability, flexibility, and a comprehensive end-to-end solution.

In May 2024, Mirus Bio LLC, a US-based biotechnology company specializing in transfection reagents and gene delivery systems for genetic research and cellular applications, acquired Merck Group for $600 million. Through this acquisition, Mirus Bio LLC seeks to expand its product portfolio and strengthen its capabilities in gene delivery technologies. Merck Group, based in Germany, is a science and technology company that produces pharmaceuticals, life science products, and specialty materials.

Major companies operating in the cell separation technologies market are Sony Corporation, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, GE HealthCare Technologies, Corning Incorporated, Lonza Group, Sartorius AG, Bio-Rad Laboratories Inc., Pall Corporation, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Stemcell Technologies Inc., 10X Genomics Inc., Cytena GmbH, Pluriselect GmbH, Akadeum Life Sciences Inc., Cellenion, NanoCellect Biomedical Inc.

North America was the largest region in the cell separation technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell separation technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell separation technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell separation technologies market consists of revenues earned by entities through cell sorting, pre-plating, cell isolation, and field flow fractionation (FFF). The market value includes the value of related goods sold by the service provider or included within the service offering. The cell separation technology market also includes sales of cell isolation kits and automated cell separation instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Separation Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell separation technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell separation technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell separation technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cell Separation Technologies market Characteristics

3. Cell Separation Technologies market Trends And Strategies

4. Cell Separation Technologies market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cell Separation Technologies Growth Analysis And Strategic Analysis Framework

6. Cell Separation Technologies market Segmentation

7. Cell Separation Technologies market Regional And Country Analysis

8. Asia-Pacific Cell Separation Technologies market

9. China Cell Separation Technologies market

10. India Cell Separation Technologies market

11. Japan Cell Separation Technologies market

12. Australia Cell Separation Technologies market

13. Indonesia Cell Separation Technologies market

14. South Korea Cell Separation Technologies market

15. Western Europe Cell Separation Technologies market

16. UK Cell Separation Technologies market

17. Germany Cell Separation Technologies market

18. France Cell Separation Technologies market

19. Italy Cell Separation Technologies market

20. Spain Cell Separation Technologies market

21. Eastern Europe Cell Separation Technologies market

22. Russia Cell Separation Technologies market

23. North America Cell Separation Technologies market

24. USA Cell Separation Technologies market

25. Canada Cell Separation Technologies market

26. South America Cell Separation Technologies market

27. Brazil Cell Separation Technologies market

28. Middle East Cell Separation Technologies market

29. Africa Cell Separation Technologies market

30. Cell Separation Technologies market Competitive Landscape And Company Profiles

31. Cell Separation Technologies market Other Major And Innovative Companies

32. Global Cell Separation Technologies market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Separation Technologies market

34. Recent Developments In The Cell Separation Technologies market

35. Cell Separation Technologies market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기